[Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities]
- PMID: 11596199
[Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities]
Abstract
Caffeine was used as a metabolic probe to measure, in 120 healthy volunteers, the activities of three enzymes, deduced to be N-acetyltransferase(NAT2), CYP1A2 and xanthine oxidase (XO). The caffeine metabolites of 5-acetylamino-6-formylamino-3-methyluracil (AFMU), 1-methylxanthine(1X), 1-methyluric acid(1U), 1, 7-dimethylxanthine(17X), and 1, 7-dimethyluric acid(17U) in urine were determined with HPLC after 4-5 hours of caffeine drink. The ratios of AFMU/1X or AFMU/(AFMU + 1X + 1U), (AFMU + 1X + 1U)/17X or (AFMU + 1X + 1U)/17U, and 1U/1X or 1U/(1X + 1U) were used as the index of NAT2, CYP1A2, and XO activities respectively. Frequency distribution analysis of the metabolic ratios of NAT2 indicated two distinct group with 20 slow acetylators and 100 rapid acetylators. Similar CYP1A2 activity was found in Chinese compared with European volunteers. Frequency analysis of CYP1A2 indicated the log normal distribution in 120 Chinese. The CYP1A2 index was much higher in smokers than that in nonsmokers. But no obvious difference was observed between young and old volunteers. The XO index also showed log normal distribution and has the similar value compared with European volunteers. The concentration variations of 1X and 1U in young volunteers were much lower than that in old volunteers.
Similar articles
-
In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.Biomed Chromatogr. 2007 Feb;21(2):190-200. doi: 10.1002/bmc.736. Biomed Chromatogr. 2007. PMID: 17221922
-
Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.Genet Epidemiol. 1994;11(2):115-29. doi: 10.1002/gepi.1370110203. Genet Epidemiol. 1994. PMID: 8013893
-
The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.Clin Pharmacol Ther. 2001 Aug;70(2):121-5. doi: 10.1067/mcp.2001.116495. Clin Pharmacol Ther. 2001. PMID: 11503005
-
Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.Curr Drug Metab. 2009 May;10(4):329-38. doi: 10.2174/138920009788499003. Curr Drug Metab. 2009. PMID: 19519341 Review.
-
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.Gen Pharmacol. 1996 Mar;27(2):245-9. doi: 10.1016/0306-3623(95)02014-4. Gen Pharmacol. 1996. PMID: 8919637 Review.
Cited by
-
Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.Eur J Drug Metab Pharmacokinet. 1998 Oct-Dec;23(4):501-6. doi: 10.1007/BF03190002. Eur J Drug Metab Pharmacokinet. 1998. PMID: 10323334 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical